There are approximately 130 new cases of pancreatic cancer in Trinidad and Tobago every year—representing about 3.2 per cent of all new cancer diagnoses nationwide. The World Health Organization ranks it as the fifth leading cause of cancer-related deaths.
Because its symptoms are non-specific in the early stages, pancreatic cancer is one of the most difficult cancers to diagnose. Hepatopancreatobiliary (HPB) surgeon Dr Fawwaz Mohammed is urging people to see a doctor if they experience any of the early symptoms.
“That’s the problem with pancreatic cancer. The early symptoms, such as unexplained weight loss, nausea, and upper abdominal pain are non-specific, because they actually present in other types of cancers too. So from the time these things start happening, what we advise is actually go see your general practitioner and get proper testing with respect to scans and blood tests and all that. And even try to see a specialist afterwards to get a proper assessment and clearance for this type of cancer.”
He said that when more specific symptoms, such as dark urine, pale stools or jaundice, appear, the disease is usually at a more advanced stage.
Pancreatic functions
The pancreas, he explained, is an organ located in the upper abdomen, just behind the stomach. It has two main functions – digestion and blood sugar regulation.
“So it breaks down all the complex carbohydrates, the complex proteins, and also some fats into smaller building block components, like amino acids. And also glucose and glucose excess, simple sugars, which could be absorbed easily.”
He said that if the tumour is located in the head or neck of the pancreas, a more specific sign is jaundice, which causes yellowing of the skin and eyes.
“And that’s because the bile duct itself is right there, and it becomes blocked because of the overgrowth of the tumour. And this also leads to the dark urine and pale stool.”
Diagnosing pancreatic cancer
Like other types of cancer, pancreatic cancer is classified into four stages, with stage four being the “unresectable metastatic stage of the disease”, meaning the cancer has spread beyond the pancreas.
“Anything that we have to remove through surgery, we basically call it a resection. Stages one and two are usually those that are resectable, and stage three would be borderline resectable.”
Mohammed explained that a cancer diagnosis can only be confirmed through a biopsy. While other tests can indicate the possible presence of cancer in other parts of the body, there are no routine screening tests for pancreatic cancer.
“There are no screening tests available for pancreatic cancer because of the location of the pancreas itself. The only way to get to see the pancreas properly, is through a CT scan of the abdomen or MRI of the pancreas, which can be extremely costly.”
Unlike breast cancer, where someone may feel a lump or undergo a mammogram or ultrasound, or colon cancer, where someone may have a colonoscopy if they notice blood in their stool, pancreatic cancer is more difficult to detect. Because the pancreas is located deep within the abdomen, he said, the disease is not usually detected until the tumour has grown considerably.
Treating pancreatic cancer
Once a biopsy confirms cancer, treatment will be determined by the stage of the disease and the patient’s overall health.
“We say that they present in thirds. So a third of them present with the disease that is spread beyond the pancreas. And unfortunately, that is unresectable and those patients tend to go to palliation. The other third presents with borderline resectable, meaning that, yes, they could be resectable if they have an upfront round of chemotherapy or radiation as the case may be. And then we reassess for resectability.”
He described the final third as patients who can proceed directly to surgery for complete resection, followed by chemotherapy.
Mohammed said that, based on worldwide data, patients with metastatic disease who receive no treatment may die within three months of diagnosis.
“And this is usually due to patients becoming septic from the jaundice, and they die because of sepsis, or cholangitis (inflammation of the bile ducts).”
Patients who choose to undergo some form of chemotherapy may live longer.
“Obviously we can’t offer them any surgery, but they have chemotherapy, and we can also drain of their jaundice by stenting. These patients, the average lifespan for them is almost nine months to a year.”
There are also patients who choose alternative approaches, including the use of medical marijuana to manage pain.
“The problem with these alternative treatments is that there’s no data to suggest that what works for one patient will work for someone else.”
At-risk demographic
The people most at risk of developing pancreatic cancer, he said, are older adults in their 70s and 80s.
“Although in some cases, recently, we’ve been seeing pancreatic cancer in some patients in their 40s and 50s, and quite recently, there was a patient in her 20s, she was a medical student and she died of pancreatic cancer.”
Patients who develop the disease at a younger age may have a genetic predisposition to pancreatic cancer.
“Again, we don’t test for those things in Trinidad and Tobago, unfortunately, so we don’t have that data.”
Another observation, he said, is that recent data suggest that an earlier increase in pancreatic cancer rates among the black population has levelled off.
“And also, there’s no male-female preponderance with respect to that. So it’s both even in both sexes.”
As with other diseases, Mohammed said, lifestyle choices can increase or reduce a person’s risk of developing pancreatic cancer.
